A Biomaterial Platform Built for Clinical Use

We use bacterial cellulose, a naturally produced material with a biologically structured nanofibrillar network as a basis for our patented graft technology. Its smooth blood-contacting surface is designed to support early tissue integration and a low inflammatory response.